Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkers

被引：0
作者：
Zev A. Wainberg
Heloisa P. Soares
Ravi Patel
Brian DiCarlo
David J. Park
Andre Liem
He-jing Wang
Lisa Yonemoto
Diego Martinez
Isett Laux
Meghan Brennan
J. Randolph Hecht
机构：
[1] David Geffen School of Medicine at University of California,Division of Hematology/Oncology, Department of Medicine
[2] Los Angeles (UCLA),Department of Biomathematics
[3] Translational Research In Oncology - US (TRIO-US),undefined
[4] Comprehensive Blood and Cancer Center,undefined
[5] Coastal Integrative Cancer Center,undefined
[6] St. Jude Crosson Cancer Institute,undefined
[7] Pacific Shores Medical Group,undefined
[8] David Geffen School of Medicine at University of California,undefined
[9] Los Angeles (UCLA),undefined
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 76卷
关键词：
Gastric cancer; Everolimus; mTOR; Biomarkers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：61 / 67
页数：6
相关论文
共 346 条
[71]  
Matsuoka T(undefined)undefined undefined undefined undefined-undefined
[72]  
Yashiro M(undefined)undefined undefined undefined undefined-undefined
[73]  
Murayama T(undefined)undefined undefined undefined undefined-undefined
[74]  
Inokuchi M(undefined)undefined undefined undefined undefined-undefined
[75]  
Takagi Y(undefined)undefined undefined undefined undefined-undefined
[76]  
Yamada H(undefined)undefined undefined undefined undefined-undefined
[77]  
Kojima K(undefined)undefined undefined undefined undefined-undefined
[78]  
Kumagai J(undefined)undefined undefined undefined undefined-undefined
[79]  
Kawano T(undefined)undefined undefined undefined undefined-undefined
[80]  
Sugihara K(undefined)undefined undefined undefined undefined-undefined
3456789101112